Sign in
4

Changes in Ownership

Mosaic ImmunoEngineering Inc. Filed Acc 0001144204-06-015658

CEO acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
POHL DAVID CEO 2006-04-13 Option exercise +50,000 $0.69 $34,500 200,000 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
POHL DAVID CEO 2005-06-22 Grant or award · 2003 Stock Option Plan (right to buy) −500,000 500,000 D: show line 2 in the form
POHL DAVID CEO 2006-04-13 Option exercise · 1996 Stock Option Plan (right to buy) −50,000 0 D: show line 3 in the form
Loading xslF345X02/v040589_ex.xml…